VANTAGEPOINT INVESTMENT ADVISERS LLCVANTAGEPOINT INVESTMENT ADVISERS LLC

Institutional investor · Portfolio as of Q4 2020

Top Holdings3 positions

Checking export access…
Activity:
AGGAGG
ETF

iShares Core U.S. Aggregate Bond ETF

2.6M$308.8M47.6%$98.65+0.91%
3 qtrssince 2020-Q2
Increased
76
IVVIVV
ETF

iShares Core S&P 500 ETF

740,332$277.9M42.8%$289.20+19.88%
3 qtrssince 2020-Q2
Increased
64
TLTTLT
ETF

iShares 20 Year Treasury Bond ETF

395,831$62.4M9.6%$122.66+7.09%
5 qtrssince 2019-Q4
Increased
95
$649.1M
AUM
3
Positions
Q4 2020
Filing
HI score · 1.0/5
Quarterly 13F Value Change
Not enough history yet
Activity profile
$ moved · Q4'20
New0%Increased100%Decreased0%Exited0%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 2.7 quarters
<1Q0%1-4Q67%1-2Y33%2Y+0%

VANTAGEPOINT INVESTMENT ADVISERS LLC manages $649.1M across 3 positions as of Q4 2020. Top holdings: AGG (47.6%), IVV (42.8%), TLT (9.6%). Fund DNA: Steady Compounder. HoldingsIntel Score: 1/5.0.

Q4 2020 Summary

Increased 3. Top move: TLT (INCREASED, conviction 95). Portfolio: $649M across 3 positions.

Top holdings by portfolio weight

Total AUM$649M
AGG47.57%
IVV42.81%
TLT9.62%

Portfolio allocation by GICS sector

Sectors1
Unknown100.00%

Behavioral investing profile

Checking access…
Steady Compounder- primarily Unknown
Compare DNA across all funds
7-dimension, SEC 13F-derived research score
Weak(1.0 / 5.0)
Holdings P&L84
Conviction49
Concentration51
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
4Q
VUGVUGVanguard Index Funds MORNINGSTAR GROWTH ETF
Q3 2025 → Q2 2026+6.8M shares+$581.2M
3Q
AVEMAVEMAVANTIS EMERGING MARKETS EQUITY ETF
Q4 2025 → Q2 2026+126,777 shares+$60.7M
2Q
VWOVWOVanguard International Equity Index Funds FTSE EMR MKT ETF
Q1 2026 → Q2 2026+521,392 shares+$44.5M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Verify source filings on SEC EDGAR

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used